"OTC Triptans in the United Kingdom" Is Now Available at Fast Market Research
In 2012 OTC triptans increased by 19% in current value terms to reach GBP7 million. Consumers continued to suffer from rising anxiety and stress levels, caused by concerns over their jobs and financial security, resulting in an increase in migraines and headaches in general.
View full press release